King's Health Accelerator 2018 Call Open
The King's Health Accelerator (KHA) call opens for its sixth year, aimed at providing financial and commercialisation support for translational life science research projects to help deliver improved patient benefit and accelerated impact. Winners can be awarded up to ca £150,000 per project per annum, selected through a peer-review process.
The streamlined process allows researchers to register their interest via a short online application, split into two stages. If interested staff working in any of KCL’s Health Faculties or King’s Health Partners (KHP) NHS member trusts have not received an e-mail invitation to this application by 20 February 2018, they can contact firstname.lastname@example.org to get a link.
Applicants will have their projects assessed for commercial appeal via peer review, and for the best ranked projects the researcher will be invited to work with King’s Commercialisation Institute (KCI) and an external specialist consultant to create a Commercial Development Plan (CDP) tailored to their project. These CDP’s will then be reviewed by a committee consisting of both internal and external individuals with significant experience in life Science and medical technology investment and commercial translation. Awards will be made on the output of these reviews.
What will winners get?
- Up to ca £150,000 annual commercial translation research funding and support per project;
- A project team to bring together the research team, a commercial portfolio manager from KCI and an IP manager from your employer organisation; and
- Specialist industrial development and regulatory knowledge and experience from KCI and partners to support the project
Call Guidelines can be found here and on the initial application that you will receive.
If you cannot access the above link to view the guidelines, please e-mail email@example.com to request a copy.